These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Tumor markers and 18F-FDG PET/CT after orchiectomy in seminoma: Is there any correlation? Dondi F, Albano D, Bertagna F, Giubbini R. Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):287-292. PubMed ID: 34425969 [Abstract] [Full Text] [Related]
43. Histologically pure stage I seminoma with an elevated beta-hCG of 4497 IU/l. Bjurlin MA, August CZ, Weldon-Linne M, Totonchi E. Urology; 2007 Nov; 70(5):1007.e13-5. PubMed ID: 18068467 [Abstract] [Full Text] [Related]
46. The predictive value of pre-orchidectomy serum tumor markers in non seminomatous germ cell tumors of the testis (N.S.G.C.T.T.). Boccon-Gibod L, Le Doze H, Steg A. Prog Clin Biol Res; 1985 Oct; 203():93-5. PubMed ID: 2421347 [Abstract] [Full Text] [Related]
55. Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992. Harland SJ. Br J Urol; 1992 Jun; 69(6):669. PubMed ID: 1379103 [No Abstract] [Full Text] [Related]
57. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA. Hautkappe AL, Lu M, Mueller H, Bex A, Harstrick A, Roggendorf M, Ruebben H. Cancer Res; 2000 Jun 15; 60(12):3170-4. PubMed ID: 10866307 [Abstract] [Full Text] [Related]